THE WOODLANDS, Texas--(BUSINESS WIRE)--Repros Therapeutics Inc.® (NasdaqCM:RPRX) today announced that its Board of Directors has approved a 1-for-4 reverse split of its common stock, which is expected to be effective upon the close of trading on October 14, 2010. The reverse split is part of the Company’s plan to regain compliance with the $1.00 minimum bid price required for continued listing on the Nasdaq Capital Market. The Company anticipates that its common stock will begin trading on a split adjusted basis on the Nasdaq Capital Market when the market opens on October 15, 2010. Beginning on that date, Repros’ common stock will trade for 20 trading days under ticker symbol “RPRXD” to provide notice of the reverse stock split. After this period, the symbol will revert to “RPRX.”
